Duncan McKechnie, EVP, Chief Commercial Officer: Vertex Pharmaceuticals VRTX Planned sale · Filed 03/11

Trade details

Type: Planned sale notice
Stock: Vertex Pharmaceuticals VRTX
Person: Duncan McKechnieEVP, Chief Commercial Officer
Planned sale date: 26/03/11
Filed: 26/03/11

More to sell after $3.6M in 3 months

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/09~04/10

Duncan McKechnie's recent trades

Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$799.8K
1,541 sh
$799.8K
Filed 07/02
Traded 07/02
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,633 sh
$1.3M
Filed 03/13
Traded 03/11
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/06
Traded 03/04
Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/04
Traded 03/04
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,500 sh
$1.2M
Filed 02/26
Traded 02/25

Duncan McKechnie, Chief Officer — plans to sell 2,633 sh of Vertex Pharmaceuticals VRTX · $1.3M · around 03/11 · 10b5-1 plan | Whalegun